The Pharmaceutical Society of Japan
Annual Awards '17
2017/11/11
1. The Pharmaceutical Society of Japan Award '17
- Novel Strategies for Enantio- and Site-Selective Molecular Transformations
Takeo Kawabata
(Institute for Chemical Research, Kyoto University, Professor) - Development of plant metabolomics and medicinal plant genomics
Kazuki Saito
(Graduate School of Pharmaceutical Sciences, Chiba University / RIKEN Center for Sustainable Resource Science, Dean, Professor / Deputy Center Director) - Development of the novel functional molecules targeting DNA and RNA
Shigeki Sasaki
(Graduate School of Pharmaceutical Sciences, Kyushu University, Professor) - In vivo Molecular Imaging
Hideo Saji
(Graduate School of Pharmaceutical Sciences, Kyoto University, Professor)
2. The Pharmaceutical Society of Japan Award for Divisional Scientific Contribution '17
- Design and Functionalization of Molecules towards Drug Discovery
Masaaki Kurihara
(National Institute of Health Sciences, Head of Division) - Development of highly sensitive analytical method for biologically relevant materials and its pharmaceutical applications.
Hidetoshi Arakawa
(Showa University, School of Pharmacy,Professor) - Imaging of sialidase activity and detection of cancer cells and viruses
Takashi Suzuki
(Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Professor)
3. The Pharmaceutical Society of Japan Award for Divisional Scientific Promotion '17
- Development of Highly Efficient Metal Nano-particle Catalyst toward Drug Discovery
Mitsuhiro Arisawa
(Osaka University, Graduate School of Pharmaceutical Sciences, Associate Professor) - Neurotoxicity mechanism of environmental chemicals and its evaluation system
Yaichiro Kotake
(Hiroshima University, Associate Professor)
4. The Pharmaceutical Society of Japan Award for Young Scientists '17
- Creation of novel toxic gas surrogates and development of safe and facile catalytic reactions
Hideyuki Konishi
(School of Pharmaceutical Sciences, University of Shizuoka, Research Assistant Professor) - Development of chemical biological tools to characterize disease-related enzymatic functions
Toru Komatsu
(Graduate School of Pharmaceutical Sciences, The University of Tokyo, Assistant Professor) - Studies on catalytic activation of olefins using cobalt complex
Hiroki Shigehisa
(Musashino University, Faculty of Pharmaceutical Sciences, Lecturer) - Studies on Divergent Syntheses of Natural Products
Jun Shimokawa
(Graduate School of Pharmaceutical Sciences, Nagoya University, Assistant Professor) - Toward understanding mechanisms underlying non-cell autonomous regulation of cellular functions
Toshihide Takeuchi
(Osaka University Graduate School of Medicine, Endowed Chair Associate Professor) - Development and evaluation of an efficient fundamental technology to identify biomarkers and drug targets
Kazuya Nagano
(Graduate School of Pharmaceutical Sciences, Osaka University, Associate Professor) - Development of a novel liposomal DDS by manipulating pharmacokinetics and intracellular trafficking for drug therapy and nucleic acid medicine
Hiroto Hatakeyama
(Chiba University, Faculty of Pharmaceutical Sciences, Assistant Professor) - Design and Synthesis of Functional π Molecules and Their Application to Near-IR Materials
Taniyuki Furuyama
(Graduate School of Natural Science and Technology, Kanazawa University, Associate Professor)
5. The Pharmaceutical Society of Japan Award for Drug Research and Development '17
- Research and Development of HIV-1 Integrase Inhibitor, Dolutegravir
Tomokazu Yoshinaga (Head of Antiviral 1, Infectious Diseases,Drug Discovery & Disease Research Laboratory, Shionogi & Co., Ltd.)
Tamio Fujiwara (HIV Integrase Inhibitor Global Project Leader, Global Development, Shionogi & Co., Ltd.)
Takashi Kawasuji (Head of Chemistry Infectious Diseases, Medicinal Chemistry Research Laboratory, Shionogi & Co., Ltd.)
Brian A. Johns (VP and Head, HIV Discovery Performance Unit, Infectious Diseases R&D, GlaxoSmithKline )
Akihiko Sato (Team Leader, Emerging Infectious Diseases, Drug Discovery & Disease Research Laboratory Shionogi & Co. Ltd.) - Discovery of alectinib, a selective ALK (anaplastic lymphoma kinase) inhibitor
Nobuhiro Oikawa (Chugai Pharmaceutical Co., Ltd. Medicinal Chemistry Research Dept. Senior Specialist)
Hiroshi Sakamoto (Chugai Pharmaceutical Co., Ltd. Safety Assessment Dept. Group Manager.)
Kenji Takanashi (Chugai Pharmaceutical Co., Ltd. Pre-Clinical Research Dept. Researcher)
Hiromi Suzuki (Chugai Pharmaceutical Co., Ltd. Safety Assessment Dept. Group Manager.)
Yasushi Yoshimura (Chugai Pharmaceutical Co., Ltd. Product Research Dept. Chugai Pharmaceutical Co. Ltd., Scientist)
6. The Pharmaceutical Society of Japan Award for Distinguished Service '17
- Toshio Fujita (Emeritus Professor, Kyoto University)
7. The 40th Sato Memorial Fund
- The development and dissemination of the Simple Suspension Method
Naomi Kurata
(Division of Community Healthcare and Pharmacy, Department of Healthcare and Regulatory Sciences, Showa University School of Pharmacy, professor)


